Ikarian Capital, LLC Chemomab Therapeutics Ltd. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Ikarian Capital, LLC holds 213,052 shares of CMMB stock, worth $289,750. This represents 0.03% of its overall portfolio holdings.
Number of Shares
213,052
Previous 213,052
-0.0%
Holding current value
$289,750
Previous $430,000
46.05%
% of portfolio
0.03%
Previous 0.07%
Shares
9 transactions
Others Institutions Holding CMMB
# of Institutions
18Shares Held
3.72MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$2.37 Million0.06% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3900KShares$1.22 Million0.26% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3578KShares$786,4750.12% of portfolio
-
Morgan Stanley New York, NY117KShares$159,3370.0% of portfolio
-
Kestra Private Wealth Services, LLC31.2KShares$42,4870.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $15.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...